Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 1 |
2018 | 1 |
2019 | 2 |
2020 | 1 |
2021 | 3 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Cost-effectiveness analysis of using innovative therapies for the management of moderate-to-severe ulcerative colitis in Spain.
Expert Rev Pharmacoecon Outcomes Res. 2022 Jan;22(1):73-83. doi: 10.1080/14737167.2021.1880324. Epub 2021 Feb 20.
Expert Rev Pharmacoecon Outcomes Res. 2022.
PMID: 33615953
Cost-utility analysis of the use of the 20-valent anti-pneumococcal vaccine (PCV20) in adults older than 60 years in Spain.
Cantarero D, Ocaña D, Onieva-García MÁ, Rodríguez-García J, Gálvez P, Méndez C, Crespo C, López-Ibáñez de Aldecoa A.
Cantarero D, et al. Among authors: lopez ibanez de aldecoa a.
Vaccine. 2023 Aug 14;41(36):5342-5349. doi: 10.1016/j.vaccine.2023.07.016. Epub 2023 Jul 20.
Vaccine. 2023.
PMID: 37479615
Free article.
Item in Clipboard
Health and economic impact of the correct diagnosis of transthyretin cardiac amyloidosis in Spain.
Formiga F, García-Pavía P, Martín Sánchez FJ, Navarro-Ruiz A, Rubio-Terrés C, Peral C, Tarilonte P, López-Ibáñez de Aldecoa A, Rubio-Rodríguez D.
Formiga F, et al. Among authors: lopez ibanez de aldecoa a.
Expert Rev Pharmacoecon Outcomes Res. 2021 Oct;21(5):1127-1133. doi: 10.1080/14737167.2021.1933948. Epub 2021 Jun 11.
Expert Rev Pharmacoecon Outcomes Res. 2021.
PMID: 34047214
Free article.
Item in Clipboard
Economic Evaluation of Combining Pharmaco- and Behavioral Therapies for Smoking Cessation in an Occupational Medicine Setting.
Rejas-Gutiérrez J, López-Ibáñez de Aldecoa A, Casasola M, Varela P, Quesada S, Olive V, Arriaza E.
Rejas-Gutiérrez J, et al. Among authors: lopez ibanez de aldecoa a.
J Occup Environ Med. 2019 Apr;61(4):318-327. doi: 10.1097/JOM.0000000000001546.
J Occup Environ Med. 2019.
PMID: 30688765
Item in Clipboard
The cost-effectiveness of isavuconazole compared to voriconazole, the standard of care in the treatment of patients with invasive mould diseases, prior to differential pathogen diagnosis in Spain.
Azanza JR, Grau S, Vázquez L, Rebollo P, Peral C, López-Ibáñez de Aldecoa A, López-Gómez V.
Azanza JR, et al. Among authors: lopez ibanez de aldecoa a.
Mycoses. 2021 Jan;64(1):66-77. doi: 10.1111/myc.13189. Epub 2020 Oct 30.
Mycoses. 2021.
PMID: 32989796
Free PMC article.
Item in Clipboard
Smoking Status and Cost of Illness in Patients with Depressive Disorder Based on the National Health Survey in Spain.
López Ibáñez de Aldecoa A, Cedillo Gómez S, Bruguera E, García-Portilla MP, Bobes J.
López Ibáñez de Aldecoa A, et al.
Subst Use Misuse. 2019;54(5):713-723. doi: 10.1080/10826084.2018.1536717. Epub 2018 Dec 26.
Subst Use Misuse. 2019.
PMID: 30585110
Item in Clipboard
Natural pyrrhotite as a catalyst in prebiotic chemical evolution.
de Aldecoa AL, Roldán FV, Menor-Salván C.
de Aldecoa AL, et al.
Life (Basel). 2013 Aug 28;3(3):502-17. doi: 10.3390/life3030502.
Life (Basel). 2013.
PMID: 25369819
Free PMC article.
Item in Clipboard
Cite
Cite